Loading…
Childhood Cancer STAR Reauthorization Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
252d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2024 · fourth_quarter · Health Issues
Became Public Law No: 117-350.
Became Public Law No: 117-350.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10025-10026)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H10025-10026)
DEBATE - The House proceeded with forty minutes of debate on S. 4120.
Considered under suspension of the rules. (consideration: CR H10025-10026)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues related to health care workforce shortages Issues related to funding for the Early Hearing Detection and Intervention Act (Public Law 117-241) and screening for Cytomegalovirus, including the Stop CMV Act (H.R. 7542/S. 3864) Issues related to funding for the allied health professional education program at the Health Resources Services Administration as expanded by Public Law 117-328) Various issues related to implementation of the ACA, including Essential Health Benefits and marketplace plans Various issues related to non-discrimination legislation and regulation Issues related to coverage of gender-affirming care/gender-affirming voice therapy Issues related to health information technology, including interoperability Issues related to funding in Fiscal Year 2025 for programs administered by the Department of Health and Human Services and National Institutes of Health H.R. 1310, States Handling Access to Reciprocity for Employment Act H.R. 2663/S. 1176, the Workplace Violence Prevention for Health Care and Social Service Workers Act Issues related to coverage of hearing devices and services, including Allys Act (H.R. 2439/S. 1135) Issues related to coverage of and support for individuals who stutter through federal health programs Issues related to funding for federal health care programs, including H.R. 5894, the Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies Act. The Long-Term Care Workforce Support Act (H.R. 7994/S. 4120) H.R. 9029, the Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025. Issues related to consolidation in the health care industry. The American Relief Act, 2025 (H.R. 10545) The Dr. Lorna Breen Health Care Provider Protection Act (H.R. 7153/S. 3679)
Client expense: $422,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2024 · third_quarter · Health Issues
Issues related to health care workforce shortages Issues related to funding for the Early Hearing Detection and Intervention Act (Public Law 117-241) and screening for Cytomegalovirus, including the Stop CMV Act (H.R. 7542/S. 3864) Issues related to funding for the allied health professional education program at the Health Resources Services Administration as expanded by Public Law 117-328) Various issues related to implementation of the ACA, including Essential Health Benefits and marketplace plans Various issues related to non-discrimination legislation and regulation Issues related to coverage of gender-affirming care/gender-affirming voice therapy Issues related to health information technology, including interoperability Issues related to funding in Fiscal Year 2025 for programs administered by the Department of Health and Human Services and National Institutes of Health H.R. 1310, States Handling Access to Reciprocity for Employment Act H.R. 2663/S. 1176, the Workplace Violence Prevention for Health Care and Social Service Workers Act Issues related to coverage of hearing devices and services, including Allys Act (H.R. 2439/S. 1135) Issues related to coverage of and support for individuals who stutter through federal health programs Issues related to funding for federal health care programs, including H.R. 5894, the Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies Act. The Long-Term Care Workforce Support Act (H.R. 7994/S. 4120) H.R. 9029, the Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025. Issues related to consolidation in the health care industry.
Client expense: $360,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2024 · second_quarter · Health Issues
Issues related to health care workforce shortages Issues related to funding for the Early Hearing Detection and Intervention Act (Public Law 117-241) and screening for Cytomegalovirus, including the Stop CMV Act (H.R. 7542/S. 3864) Issues related to funding for the allied health professional education program at the Health Resources Services Administration as expanded by Public Law 117-328) Various issues related to implementation of the ACA, including Essential Health Benefits and marketplace plans Various issues related to non-discrimination legislation and regulation Issues related to coverage of gender-affirming care/gender-affirming voice therapy FDA regulation of over-the-counter hearing aids Issues related to health information technology, including interoperability Issues related to funding in Fiscal Year 2025 for programs administered by the Department of Health and Human Services and National Institutes of Health H.R. 1310, States Handling Access to Reciprocity for Employment Act H.R. 2663/S. 1176, the Workplace Violence Prevention for Health Care and Social Service Workers Act Issues related to coverage of hearing devices and services, including Allys Act (H.R. 2439/S. 1135) Issues related to coverage of and support for individuals who stutter through federal health programs Issues related to funding for federal health care programs, including H.R. 5894, the Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies Act. The Long-Term Care Workforce Support Act (H.R. 7994/S. 4120)
Client expense: $290,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2024 · first_quarter · Health Issues
Issues related to health care workforce shortages Issues related to funding for the Early Hearing Detection and Intervention Act (Public Law 117-241) and screening for Cytomegalovirus, including the Stop CMV Act (H.R. 7542/S. 3864) Issues related to funding for the allied health professional education program at the Health Resources Services Administration as expanded by Public Law 117-328) Various issues related to implementation of the ACA, including Essential Health Benefits and marketplace plans Various issues related to non-discrimination legislation and regulation Issues related to coverage of gender-affirming care/gender-affirming voice therapy FDA regulation of over-the-counter hearing aids Issues related to funding in Fiscal Year 2024 for programs administered by the Department of Health and Human Services and National Institutes of Health H.R. 1310, States Handling Access to Reciprocity for Employment Act H.R. 2663/S. 1176, the Workplace Violence Prevention for Health Care and Social Service Workers Act Issues related to coverage of hearing devices and services, including Allys Act (H.R. 2439/S. 1135) Issues related to coverage of and support for individuals who stutter through federal health programs Issues related to funding for federal health care programs, including H.R. 5894, the Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies Act. S. 4120, the Long-Term Care Workforce Support Act H.R. 2882, the Further Consolidated Appropriations Act of 2024
Client expense: $350,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
2022 · fourth_quarter · Health Issues
Funding for the National Institutes of Health The Childhood Cancer STAR Reauthorization Act (S.4120/H.R.7630)
Client expense: Not reported · Firm income: $37,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
PDUFA childhood cancer issues; LHHS and FDA appropriations; Childhood Cancer STAR Reauthorization Act, S. 4120/HR 7630; HR 9565/S. 5295 Comprehensive Cancer Survivorship Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Medical/Disease Research/Clinical Labs
HR 7630 / S 4120, Childhood Cancer STAR Reauthorization Act; HR 3773 / S 1357, the Pediatricians Accelerate Childhood Therapies (PACT) Act; HR 623, the Gabriella Miller Kids First Act
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Health Issues
Issues related to health insurance, including Medicare, Medicaid and short term plans. Issues related to prescription drug costs and affordability. Issues related to the No Surprises Act and patient protections. Issues related to agency funding for medical and cancer research. Issues related to H.R. 3089/S. 1544, the Accelerating Kids' Access to Care Act and H.R. 7630/S.4120, the Childhood Cancer STAR Reauthorization Act. Issues related to clinical trial diversity including H.R. 5030/S.2706, DIVERSE Trials Act, in H.R. 6584, DEPICT Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
S 464/HR 2163 Safe Step Act - implementing safe guards around step therapy (fail first) programs in ERISA regulated plans HR 1550 - PREVENT HPV Cancers Act of 2021 HR 3258 - TACT Act of 2021- improve patient access to anti-cancer oral medications HR 4385/S 3080- Cancer Drug Parity Act of 2021- oral parity HR 5801- HELP Copays Act- copay accumulator programs S 3039/HR 2503- Social Determinants Accelerator Act of 2021- SDOH HR 5030/S 2706- DIVERSE Trials Act- access to clinical trials HR 6584- DEPICT Act- access to clinical trials HR 6000- Cures 2.0 HR 5963/S 3611- Provider Relief Fund Improvement Act- extends deadlines, expands the uses of, and makes other changes pertaining to the Provider Relief Fund HR 4450/S 2352- Access to Infertility Treatment and Care Act- requires private insurance to cover fertility preservation services ARPA-H FDA User Fee Agreement policy riders: increasing diversity in clinical trials, improvements to accelerated approval pathway, expanded use of real world data, and in vitro clinical tests HR 7630/S 4120- Childhood Cancer STAR Reauthorization Act of 2022- reauthorizes the STAR Act through FY2028 S 4293- Pharmacy Benefit Manager Transparency Act of 2022- prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S 4430- Interagency Patent Coordination and Improvement Act of 2022- establishes an interagency taskforce between the United States Patent and Trademark Office and the FDA S 5295/HR 9565- Comprehensive Cancer Survivorship Act- addresses the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment HR 4128/S 2209- VALID Act of 2021- requires FDA to regulate in vitro clinical tests
2022 · third_quarter · Health Issues
Funding for the National Institutes of Health The Childhood Cancer STAR Reauthorization Act (S.4120/H.R.7630)
Client expense: Not reported · Firm income: $37,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medical/Disease Research/Clinical Labs
HR 7630 / S 4120, Childhood Cancer STAR Reauthorization Act; HR 3773 / S 1357, the Pediatricians Accelerate Childhood Therapies (PACT) Act; HR 623, the Gabriella Miller Kids First Act
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Health Issues
S 464/HR 2163 Safe Step Act - implementing safe guards around step therapy (fail first) programs in ERISA regulated plans HR 1550 - PREVENT HPV Cancers Act of 2021 HR 3258 - TACT Act of 2021- improve patient access to anti-cancer oral medications HR 4385/S 3080- Cancer Drug Parity Act of 2021- oral parity HR 5801- HELP Copays Act- copay accumulator programs S 3039/HR 2503- Social Determinants Accelerator Act of 2021- SDOH HR 5030/S 2706- DIVERSE Trials Act- access to clinical trials HR 6584- DEPICT Act- access to clinical trials HR 6000- Cures 2.0 HR 5963/S 3611- Provider Relief Fund Improvement Act- extends deadlines, expands the uses of, and makes other changes pertaining to the Provider Relief Fund HR 4450/S 2352- Access to Infertility Treatment and Care Act- requires private insurance to cover fertility preservation services ARPA-H FDA User Fee Agreement policy riders: increasing diversity in clinical trials, improvements to accelerated approval pathway, expanded use of real world data, and in vitro clinical tests HR 7630/S 4120- Childhood Cancer STAR Reauthorization Act of 2022- reauthorizes the STAR Act through FY2028 S 4293- Pharmacy Benefit Manager Transparency Act of 2022- prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S 4430- Interagency Patent Coordination and Improvement Act of 2022- establishes an interagency taskforce between the United States Patent and Trademark Office and the FDA
Client expense: $125,406 · Firm income: Not reported
2022 · third_quarter · Health Issues
Legislation involving survivorship coverage; PDUFA childhood cancer issues; LHHS and FDA appropriations; Childhood Cancer STAR Reauthorization Act, S. 4120/HR 7630.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medical/Disease Research/Clinical Labs
HR 7630 / S 4120, Childhood Cancer STAR Reauthorization Act; HR 3773 / S 1357, the Pediatricians Accelerate Childhood Therapies (PACT) Act; HR 623, the Gabriella Miller Kids First Act
Client expense: $170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Funding for the National Institutes of Health The Childhood Cancer STAR Reauthorization Act (S.4120/H.R.7630)
Client expense: Not reported · Firm income: $37,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Legislation involving survivorship coverage; PDUFA childhood cancer issues; LHHS and FDA appropriations; Childhood Cancer STAR Reauthorization Act, S. 4120/HR 7630.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Mr. Pallone moved to suspend the rules and pass the bill.
Held at the desk.
Received in the House.
Message on Senate action sent to the House.
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S9613-9614)
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S9613-9614)
Measure laid before Senate by unanimous consent. (consideration: CR S9613-9614)
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2221)
Introduced in Senate
| -- |
| Democratic |
| MD |
| Catherine Cortez Masto | Democratic | NV |
| Chris Van Hollen | Democratic | MD |
| Chuck Grassley | Republican | IA |
| Cindy Hyde-Smith | Republican | MS |
| Cory A. Booker | Democratic | NJ |
| Dan Sullivan | Republican | AK |
| Debbie Stabenow | Democratic | MI |
| Jacky Rosen | Democratic | NV |
| James E. Risch | Republican | ID |
| Joe Manchin, III | Independent | WV |
| John Boozman | Republican | AR |
| Kyrsten Sinema | Independent | AZ |
| Lisa Murkowski | Republican | AK |
| Marco Rubio | Republican | FL |
| Mark Kelly | Democratic | AZ |
| Michael F. Bennet | Democratic | CO |
| Mike Crapo | Republican | ID |
| Richard Blumenthal | Democratic | CT |
| Rick Scott | Republican | FL |
| Rob Portman | Republican | OH |
| Robert Menendez | Democratic | NJ |
| Robert P. Casey, Jr. | Democratic | PA |
| Roger F. Wicker | Republican | MS |
| Roger Marshall | Republican | KS |
| Sheldon Whitehouse | Democratic | RI |
| Shelley Moore Capito | Republican | WV |
| Sherrod Brown | Democratic | OH |
| Steve Daines | Republican | MT |
| Susan M. Collins | Republican | ME |
| Tammy Baldwin | Democratic | WI |
| Tammy Duckworth | Democratic | IL |
| Thom Tillis | Republican | NC |
| Tina Smith | Democratic | MN |
| Todd Young | Republican | IN |
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE